510(k) Report

510(k) · Cleared

Cleared

MR Syringe Dual Pack for Solaris Injectors

K161471510(k) TraditionalCleared Oct 6, 2016132-day reviewClass II21 CFR 870.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Coeur, Inc. · DXT Injector And Syringe, Angiographic

Cleared on Oct 6, 2016 as substantially equivalent to K033247 (Medrad, Inc., 2003) after a 132-day review. Its family tree reaches back 2 generations to 2001. 1 later device descends from it.

Decided
Oct 6, 2016
Review
132 days
Class
Class II
Product code
DXT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K012950 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 2 generations backK012950 Modification to: Medrad Spectris Solaris MR Injector SystemMedrad, Inc. · 2001
  2. 1 generation backK033247 Medrad Spectris Solaris MR Injector SystemMedrad, Inc. · 2003
  3. This deviceK161471 MR Syringe Dual Pack for Solaris InjectorsCoeur, Inc. · 2016
  4. Descendant · cites it directly · 0 of its ownK170431 CT Syringe for Stellant Injectors (with & without Spikes, Prime…Coeur, Inc. · 2017

Most influential descendants

Showing 1 of 1 · See all
  • K170431CT Syringe for Stellant Injectors (with & without Spikes, Prime Tubes, & Fill Tubes), CT…Coeur, Inc. · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K012950Modification to: Medrad Spectris Solaris MR Injector SystemMedrad, Inc.2001—
−1K033247Medrad Spectris Solaris MR Injector SystemMedrad, Inc.2003—
0 (this device)K161471MR Syringe Dual Pack for Solaris InjectorsCoeur, Inc.2016—
+1K170431CT Syringe for Stellant Injectors (with & without Spikes, Prime Tubes, & Fill…Coeur, Inc.2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
FIG. 1 — Lineage of K161471, 2001–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033247Medrad Spectris Solaris MR Injector System
Summary page 4
…lly Marketed Devices to which Substantial Equivalence is claimed: Primary Predicate Device Medrad: Syringe Included in Spectris Solaris MR Injection System (K033247) Referenced Devices Coeur:  Coeur 130mL Syringe (K971712)  Coeur Syringes for Nemoto Injectors…
Medrad, Inc.2003—
†K971712Coeur 130 ML Angiographic SyringeCoeur Laboratories, Inc.1997—
†K051799Disposable CT/MR Syringes for Nemoto InjectorsCoeur, Inc.2005—
†K120892Disposable 330PSI Extension LinesCoeur, Inc.2013—
†K140469MR Syringe Dual PackCoeur, Inc.2014—
†K062449Empowermr Injector System, Model 9730E-Z-Em, Inc.2007—

Also cleared against K033247: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K170431CT Syringe for Stellant Injectors (with & without Spikes, Prime Tubes, & Fill Tubes), CT…Coeur, Inc.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 2 companies; a new generation was cleared every 12.9 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K170431 (Coeur, Inc., 2017) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K033247.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—

What is it indicated for?

For use with the Medrad Spectris® Solaris™ MR Injection System for the injection of contrast media or saline to the vascular system for diagnostic purposes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161471: MR Syringe Dual Pack for Solaris Injectors.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K161471

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026